OS Therapies grants CFO 750,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
OS Therapies Inc (OSTX) Chief Financial Officer Francis Knuettel II received 250,000 restricted stock units (RSUs) and options to purchase 750,000 common shares on November 10, 2026. The options have a $0.89 exercise price and expire November 10, 2036. For both awards, 20% vested on the grant date; the remaining 80% vest in 12 equal quarterly installments from December 31, 2026 through September 30, 2029, provided he remains an employee on each vesting date. He also reported 20,000 common shares held by the Lara Knuettel Revocable Trust; he is its co-trustee and disclaims beneficial ownership except to the extent of his pecuniary interest.
Insider Trade Summary
Grant/Award: 1,000,000 shares
Grant/Award
2 txns
Insider
Francis Knuettel II
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock options (right to buy) F3 | 750,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 250,000 | $0.00 | $0.00 |
| Holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Stock options (right to buy) — 750,000 options (Direct);
Common Stock — 250,000 shares (Direct);
Common Stock — 20,000 shares (Indirect, By Lara Knuettel Revocable Trust)
Footnotes (3)
- F1. On November 10, 2026 (the "Grant Date"), the reporting person was granted 250,000 restricted stock units ("RSUs") pursuant to the terms and conditions of a restricted stock unit award agreement and the issuer's amended and restated 2023 incentive compensation plan. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and settlement. 20% of the RSUs vested on the Grant Date, and the remaining 80% vest in 12 equal quarterly installments on the last day of each calendar quarter, commencing December 31, 2026 and ending September 30, 2029, provided that the reporting person is serving as an employee of the issuer on each applicable vesting date.
- F2. The reporting person is the co-trustee of the Lara Knuettel Revocable Trust and may be deemed to beneficially own the shares of common stock held of record by such trust. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- F3. On the Grant Date, the reporting person was granted options to purchase 750,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and the issuer's amended and restated 2023 incentive compensation plan. 20% of these options vested on the Grant Date, and the remaining 80% vest in 12 equal quarterly installments on the last day of each calendar quarter, commencing December 31, 2026 and ending September 30, 2029, provided that the reporting person is serving as an employee of the issuer on each applicable vesting date.
Key Figures
Restricted stock units granted: 250,000 RSUs
Options granted: 750,000 options
Option exercise price: $0.89 per share
+4 more
7 metrics
Restricted stock units granted
250,000 RSUs
Granted to Francis Knuettel II on November 10, 2026
Options granted
750,000 options
Options to purchase common shares, granted November 10, 2026
Option exercise price
$0.89 per share
Exercise price for the options granted to Francis Knuettel II
Vested on grant date
20%
Applied to both the RSUs and options on November 10, 2026
Remaining vesting
80% in 12 equal quarterly installments
Both awards; subject to continued employment on each applicable vesting date
Trust-held common shares
20,000 shares
Held by the Lara Knuettel Revocable Trust
Option expiration
November 10, 2036
Expiration date for the options granted November 10, 2026
Key Terms
restricted stock units, contingent right, stock option award agreement, pecuniary interest
4 terms
restricted stock units financial
"granted 250,000 restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each RSU represents a contingent right to receive one share"
stock option award agreement financial
"pursuant to the terms and conditions of a stock option award agreement"
A stock option award agreement is a legal document that gives a person the right to buy a company’s shares at a fixed price later, with clear rules about when those rights become usable, how long they last, and any conditions for exercising them. For investors it matters because these agreements can increase the total shares outstanding and affect company costs and incentives—like a coupon that can turn into new stock, changing ownership and future stock supply.
pecuniary interest financial
"except to the extent of his pecuniary interest therein"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What awards did the OS Therapies (OSTX) CFO receive?
Francis Knuettel II received 250,000 RSUs and options to purchase 750,000 common shares on November 10, 2026. The options have a $0.89 exercise price and expire November 10, 2036.
AI-generated analysis. How Rhea-AI works. Not financial advice.
